Efficacy of olanzapine long-acting injection in patients with acutely exacerbated schizophrenia: an insight from effect size comparison with historical oral data Full Text
BMC Psychiatry,  Clinical Article

Detke HC et al. – Patients treated acutely with olanzapine long–acting injection (LAI) showed a similar pattern of improvement to that seen historically with oral olanzapine. With the exception of injection–related adverse events, the efficacy and tolerability profile of olanzapine LAI is similar to oral olanzapine.

Methods
  • Six-week results from the olanzapine LAI study (N=404) were compared with those of 3 oral studies (study 1: olanzapine vs. haloperidol vs. placebo [N=335]; study 2: olanzapine vs. haloperidol vs. low-dose olanzapine [N=431]; study 3: olanzapine vs. placebo vs. low-dose olanzapine [N=152]).
  • All patients had baseline Brief Psychiatric Rating Scale (BPRS) scores >=24 (0-6 scale).
  • Six-week effect sizes were calculated.
  • Efficacy onset, pharmacokinetics, discontinuations, weight gain, and extrapyramidal symptoms were also assessed.

Results
  • At 6 weeks, mean BPRS scores decreased by 14 to 15 points for olanzapine LAI (405 mg/4 weeks, 210 or 300 mg/2 weeks), by 8 to 16 for oral olanzapine (10+/-2.5 or 15+/-2.5 mg/day), and by 12 to 13 for haloperidol (15+/-5 mg/day).
  • For those same dose groups, effect sizes vs. placebo for the BPRS were 0.7 to 0.8 for olanzapine LAI, 0.5 to 0.7 for oral olanzapine, and 0.6 for haloperidol.
  • The first statistically significant separation from placebo on the BPRS occurred at 3 days for the olanzapine LAI groups and at 1 week for oral olanzapine and haloperidol (15+/-5 mg/day) in oral study 1 although as late as week 6 for the 10-mg/day olanzapine dose in oral study 3.
  • Olanzapine concentrations were similar across studies.
  • Weight gain >=7% of baseline occurred in up to 35% of olanzapine LAI and oral patients versus up to 12% of haloperidol and placebo patients.
  • Extrapyramidal symptoms were lowest in the olanzapine LAI groups and significantly greater in the haloperidol groups.
  • No post-injection delirium/sedation syndrome events occurred in the olanzapine LAI study.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Psychiatry

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Psychiatry Articles

1 Atypical antipsychotics olanzapine, quetiapine, and risperidone and risk of acute major cardiovascular events in young and middle-aged adults: A nationwide register-based cohort study in Denmark CNS Drugs, June 18, 2014    Clinical Article

2 Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis FOCUS, June 16, 2014    Evidence Based Medicine

3 Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials Psychosomatic Medicine, March 20, 2014    Evidence Based Medicine    Review Article    Clinical Article

4 Re-evaluating the role of antidepressants in cancer-related depression: A systematic review and meta-analysis General Hospital Psychiatry, June 4, 2014    Evidence Based Medicine

5 Does pharmacological treatment of ADHD in adults enhance parenting performance?: Results of a double-blind randomized trial CNS Drugs, June 12, 2014    Clinical Article

6 Association between C-reactive protein and depression: modulated by gender and mediated by body weight Psychiatry Research, June 19, 2014    Clinical Article

7 A comparison of the effects of hatha yoga and resistance exercise on mental health and well-being in sedentary adults: A pilot study Complementary Therapies in Medicine, June 20, 2014    Clinical Article

8 Attachment anxiety is related to epstein-barr virus latency Brain, Behavior, and Immunity, June 23, 2014    Clinical Article

9 Pretreatment brain states identify likely nonresponse to standard treatments for depression Biological Psychiatry, May 23, 2014    Clinical Article

10 Physical diseases among persons with obsessive compulsive symptoms and disorder: A general population study Social Psychiatry and Psychiatric Epidemiology, June 13, 2014    Clinical Article

11 Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapy CNS Spectrums, May 30, 2014    Clinical Article

12 Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study BMJ, June 24, 2014    Evidence Based Medicine    Clinical Article

13 A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan war veterans American Journal of Psychiatry, June 9, 2014    Clinical Article

14 A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population- A meta-analysis of 31 studies Full Text BMC Psychiatry, May 20, 2014    Free full text    Evidence Based Medicine    Clinical Article

15 Predicting autism diagnosis by 7 years of age using parent report of infant social communication skills Journal of Paediatrics and Child Health, June 10, 2014    Clinical Article

16 Risk of myocardial infarction and stroke in bipolar disorder: A systematic review and exploratory meta-analysis Acta Psychiatrica Scandinavica, June 2, 2014    Evidence Based Medicine    Review Article

17 Myofascial pain in war veterans with post-traumatic stress disorder Journal of Musculoskeletal Pain , June 11, 2014    Clinical Article

18 Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: A randomized double blind placebo controlled clinical trial Journal of Affective Disorders, June 9, 2014    Clinical Article

19 Elevated fetal steroidogenic activity in autism Full Text Molecular Psychiatry, June 25, 2014    Free full text    Clinical Article

20 Eveningness and insomnia: independent risk factors of nonremission in major depressive disorder SLEEP, May 7, 2014    Clinical Article

Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addictionmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close